Evaluation of Recombinant Factor VIIa Treatment for Massive Hemorrhage in Patients with Multiple Traumas

BACKGROUND: Recent studies and case reports have shown that recombinant factor VIIa (rFVIIa) treatment is effective for reversing coagulopathy and reducing blood transfusion requirements in trauma patients with life-threatening hemorrhage. The purpose of this study is to evaluate the effect of rFVII...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Koh, Young Rae, Cho, Suck Ju, Yeom, Seok Ran, Chang, Chulhun L., Lee, Eun Yup, Son, Han Chul, Kim, Hyung Hoi
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Society for Laboratory Medicine 2012
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3289780/
https://ncbi.nlm.nih.gov/pubmed/22389882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3343/alm.2012.32.2.145
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky